Peer Comparison Feedback to Providers to Improve Hypertension Control
1 other identifier
interventional
93
1 country
1
Brief Summary
As part of a roll out of new payment model for physicians based on hypertension control, the investigators will evaluate a monthly peer comparison message to Primary Care Providers at Penn Medicine Lancaster to see whether provider engagement with patients' overall hypertension management increases, as measured by new or increasing doses of anti-hypertensive medications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hypertension
Started Apr 2022
Longer than P75 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 9, 2021
CompletedFirst Posted
Study publicly available on registry
December 16, 2021
CompletedStudy Start
First participant enrolled
April 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 6, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedDecember 4, 2025
December 1, 2025
6 months
November 9, 2021
December 3, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in new hypertensive medication prescriptions or an increased dose of hypertensive medication
Change in new hypertensive medication prescriptions or an increased dose of hypertensive medication from baseline to the follow up period, as measured by the proportion of patients with a new prescription or dose placed for hypertensive medications in the electronic health record (EHR) from baseline to follow-up
6 months
Secondary Outcomes (1)
Change in hypertension control percentage
6 months
Study Arms (2)
Control
NO INTERVENTIONThis group will not receive peer comparison messages and will continue with usual care.
Intervention
EXPERIMENTALThis group will receive peer comparison messages.
Interventions
In addition to usual care, PCPs will receive a monthly report as an EPIC in basket message describing what category they are in: 1. If HTN control rate \<50th percentile, PCP is told they are below median 2. If HTN control rate is between 50-89th percentile , PCP is told they are below top performer 3. If HTN control rate is between 90-100th percentile, PCP is told they are a high performer
Eligibility Criteria
You may qualify if:
- Primary Care Providers who have at =\>30 patients hypertension as determined by the HTN quality metric
- Patients aged 18-85 with hypertension in their encounter diagnosis within the last 2 years (office visits, ED/Urgent Care, Hospital, Hospital Encounter, and Prenatal Visit)
- Patients will be counted in the denominator of the quality metric if they have both systolic and diastolic BP measures from an encounter with their PCP department within the last year (including office visits, well child, prenatal visit, consult visit, confidential, e-visit, nursing only, home/offsite visit, and telemedicine) that is \>140 for systolic BP and \>90 diastolic BP
You may not qualify if:
- Primary Care Providers includes providers with \<30 patients in the HTN quality metric
- Patients will be excluded if they are 66 and older with a frailty diagnosis and those with an advanced illness diagnosis within the past year; 81 and older with frailty diagnosis within the past year
- It also excludes patients with end stage renal disease (indicated by evaluation of the GFR, diagnosis of end stage renal disease in last year, dialysis received in last year, or renal transplant) and patients with a pregnancy diagnosis in the last 9 months
- It also excludes patients with an end of life indicator (comfort care encounter in last year, comfort care noted in problem list in last year, and comfort care/palliative care procedures in last year)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lancaster General Hospital
Lancaster, Pennsylvania, 17602, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shivan Mehta, MD,MBA,MSHP
University of Pennsylvania
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 9, 2021
First Posted
December 16, 2021
Study Start
April 5, 2022
Primary Completion
October 6, 2022
Study Completion
April 1, 2026
Last Updated
December 4, 2025
Record last verified: 2025-12